<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Growthduck6</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Growthduck6"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Growthduck6"/>
		<updated>2026-04-18T08:44:57Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Zika_Neural_Stem_Cells&amp;diff=195304</id>
		<title>Zika Neural Stem Cells</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Zika_Neural_Stem_Cells&amp;diff=195304"/>
				<updated>2017-06-28T10:03:55Z</updated>
		
		<summary type="html">&lt;p&gt;Growthduck6: Створена сторінка: : human participants without the need of limitation of sex or geographic place, case-control or cohort research, prior health-related history of RA as exposure,...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;: human participants without the need of limitation of sex or geographic place, case-control or cohort research, prior health-related history of RA as exposure, MM as outcome, research that reported relative threat, standardized incidence ratio or odds ratio of MM sufferers with prior history of RA, publication in English. Also, the selection of cohort research for inclusion was created regardless of precise RA management tactics. When duplicate reports for precisely the same population and data supply had been eligible, we chose the original reports using the largest sample size. Case series, case reports, in vitro and animal research were excluded. Eligibility assessment was performed independently by two reviewers, and disagreements resolved by consensus. The Newcastle-Ottawa Scale, developed for evaluating the excellent of nonrandomized studies, was utilized by two independent reviewers to assess the methodological high-quality of every single study, along with the scores subsequently applied in subgroup analysis. A score of #5 was deemed as relative low good quality. Statistical Analyses In case-control studies, OR and 95% CIs for MM danger factors had been straight extracted from original research papers or calculated when not offered. The key outcome for cohort research was SIR and corresponding 95% CI. In cases where SIRs had been not specifically reported, calculations had been produced from the variety of observed MM divided by the number of expected instances within the common population provided by authors, and 95% CI determined working with the regular error on the natural logarithm of SIR, estimated from the inverse with the square root of your observed variety of instances. The measure of interest was RR, estimated from ORs in case-control studies and SIRs in cohort studies. Since the incidence of MM is low, SIR and OR create related estimate of RR, as a result we present all results as RR for simplicity. Between-study heterogeneity was examined employing a chi-square test of heterogeneity and I2 measure of inconsistency. P-values less than 0.1 or the I2 statistic higher than 50% were regarded as statistically substantial. Under these circumstances, data have been pooled based on the method of Dersimonian and Laird below a random effects model otherwise under fixed effects model. Twotailed p#0.05 was considered statistically [http://www.medchemexpress.com/GW3965-hydrochloride.html GW3965 (hydrochloride) web] substantial for all analyses. To evaluate publication bias, we constructed a funnel plot and applied Begg's test. Trim and Fill evaluation was utilized to estimate the number of missing studies and their prospective effects on outcomes. Sensitivity analyses were also carried out to ascertain the robustness of our findings. The influence of RA was examined by excluding studies restricted to elderly sufferers or Data Extraction Two authors performed information extraction independently, and any discrepancies were addressed by discussion and re-evaluation. We obtained data on the author, year of publication, country of origin, source of case, manage and cohort, controlled aspects, diagnosis criteria and remedy regimen for RA. Cohort size, number of situations, cohort duration, SIR and 95% self-assurance intervals or enough data to allow calculation of these numbers have been also vital for  cohort studies. For casecontrol studies, the precise numbers of situations and controls by RA, OR and 95% CIs were essential. For the purpose of ascertaining the connection amongst MM as well as other  autoimmune illnesses, associated information had been recorded, where accessible, based on the above extraction principles.&lt;/div&gt;</summary>
		<author><name>Growthduck6</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Title_Loaded_From_File&amp;diff=194858</id>
		<title>Title Loaded From File</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Title_Loaded_From_File&amp;diff=194858"/>
				<updated>2017-06-27T10:03:35Z</updated>
		
		<summary type="html">&lt;p&gt;Growthduck6: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;F M+F M+F Population 111 19 001 567 74 841 0.80 Age, gender, residence Population 263 9 211 three 289 119 242 1.00 Population 7 172 9 682 two.30 none Gender, year of diagnosis, age at diagnosis Hospital 12 85 five 95 2.60 Age, gender, residence Population 64 509 241 1 890 0.80 Age, gender, race Population 39 89 164 348 0.90 Age, gender, race, residence Hospital 62 91 203 210 0.70 Age, gender, race, disease status Population 4 72 7 308 two.30 Age, registration year Non-RA RA Non-RA Year Country Sex Controls Situations OR Controlled Aspects Controls Pearce NE 1986 New Zealand Cohen HJ 1987 USA Nation Finland Denmark Finland England USA USA USA USA Sweden Denmark M+F 7 159 M+F 72 309 M+F 84 475 M M+F 2 982 two 94 64 81 four M+F 7 830 19 M+F 26 623 38 M+F 9 469 eight M+F 20 699 21 M+F 46 101 28 Sex [http://www.medchemexpress.com/HG6-64-1.html HG 6-64-1 biological activity] Cohort Size Quantity of MM SIR two.20 1.10 1.20 1.66 2.00 2.36 1.17 0.90 0.88 1.76 Follow-up Duration 213 911 144 421 65 391 151 987 33 410 7 791 27 years 405 540 731 954 24 811 Boffetta P 1989 USA Lewis DR 1994 USA Vlajinac HD 2003 Yugoslavia Landgren O 2006 USA Anderson LA 2009 USA Lindqvist EK 2011 Sweden Abbreviations: RA, rheumatoid arthritis; OR, odds ratio; CI, self-confidence intervals; M, male; F, female. Excludes research by the groups of Pearce, Landgren and Brown. Excludes studies by the groups of Pearce and Landgren. Abbreviations: N, number; RR, relative threat; NS, not substantial; CI, confidence interval. doi:ten.1371/journal.pone.0091461.t003 4 Several Myeloma in Rheumatoid Arthritis I2 72.9 54.6 75.7 71.3 72.7 64.three 61.four 80.9 67.3 72.0 75.9 70.four 77.7 80.four 71.2 eight.1 69.1 59.5 62.five 45.9 77.9 47.eight 80.6 Subgroup Overall Study design Analyses Cohort Case-control RR 1.32 0.92 1.ten 1.15 1.29 0.95 1.02 1.30 1.48 1.25 1.36 1.17 1.25 1.37 1.63 1.17 0.81 1.02 1.14 0.88 0.91 1.28 0.92 1.22 p-value,0.001 0.031,0.001,0.001,0.001 0.024 0.008,0.001 0.047 0.002,0.001 0.017,0.001,0.001 0.015 0.352 0.021 0.060 0.046 0.116 0.033 0.088 0.023 Publication year Prior to 2000 Following 2000 Study good quality Regiona NOS#5 NOS.5 USA Europe Cohort Publication year Just before 2000 Immediately after 2000 Study good quality NOS#5 NOS.five Area Mean follow-upb USA Europe ,five years $5 years Case-control Publication year Just before 2000 Immediately after 2000 Study high-quality Regiona NOS#5 NOS.five USA Europe Manage variety Population Hospital Abbreviations: N, number; M, male; F, female; RR, relative danger; NOS, Newcastle-Ottawa Scale.&lt;/div&gt;</summary>
		<author><name>Growthduck6</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Kinds_Of_Stem_Cells&amp;diff=191789</id>
		<title>Kinds Of Stem Cells</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Kinds_Of_Stem_Cells&amp;diff=191789"/>
				<updated>2017-06-20T11:43:38Z</updated>
		
		<summary type="html">&lt;p&gt;Growthduck6: Створена сторінка: : human participants without the need of limitation of sex or geographic place, case-control or cohort research, prior medical history of RA as exposure, MM as...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;: human participants without the need of limitation of sex or geographic place, case-control or cohort research, prior medical history of RA as exposure, MM as outcome, research that reported relative danger, standardized incidence ratio or odds ratio of MM patients with prior history of RA, publication in English. In addition, the collection of cohort studies for inclusion was made irrespective of specific RA management methods. When duplicate reports for the same population and data supply had been eligible, we chose the original reports with the largest sample size. Case series, case reports, in vitro and animal research have been excluded. Eligibility assessment was performed independently by two reviewers, and disagreements resolved by consensus. The Newcastle-Ottawa Scale, created for evaluating the high-quality of nonrandomized research, was applied by two independent reviewers to assess the methodological high quality of each study, plus the scores subsequently made use of in subgroup analysis. A score of #5 was considered as relative low good quality. Statistical [http://www.medchemexpress.com/GW2580.html GW-2580 chemical information] analyses In case-control studies, OR and 95% CIs for MM danger variables had been straight extracted from original investigation papers or calculated when not provided. The major outcome for cohort research was SIR and corresponding 95% CI. In circumstances exactly where SIRs have been not particularly reported, calculations have been made from the variety of observed MM divided by the amount of expected cases in the general population provided by authors, and 95% CI determined making use of the standard error of your natural logarithm of SIR, estimated in the inverse of your square root of your observed number of instances. The measure of interest was RR, estimated from ORs in case-control studies and SIRs in cohort studies. Because the incidence of MM is low, SIR and OR make related estimate of RR, therefore we present all results as RR for simplicity. Between-study heterogeneity was examined using a chi-square test of heterogeneity and I2 measure of inconsistency. P-values much less than 0.1 or the I2 statistic greater than 50% were deemed statistically considerable. Under these conditions, data have been pooled based around the system of Dersimonian and Laird under a random effects model otherwise beneath fixed effects model. Twotailed p#0.05 was regarded as statistically important for all analyses. To evaluate publication bias, we constructed a funnel plot and applied Begg's test. Trim and Fill analysis was utilised to estimate the number of missing studies and their potential effects on outcomes. Sensitivity analyses had been furthermore carried out to ascertain the robustness of our findings. The influence of RA was examined by excluding studies restricted to elderly sufferers or Information Extraction Two authors performed information extraction independently, and any discrepancies have been addressed by discussion and re-evaluation. We obtained information on the author, year of publication, nation of origin, supply of case, handle and cohort, controlled elements, diagnosis criteria and treatment regimen for RA. Cohort size, variety of circumstances, cohort duration, SIR and 95% self-confidence intervals or enough information to let calculation of those numbers had been moreover needed for  cohort research. For casecontrol research, the exact numbers of cases and controls by RA, OR and 95% CIs had been expected. For the purpose of ascertaining the relationship among MM along with other  autoimmune illnesses, associated information were recorded, where readily available, in accordance with the above extraction principles. 2 Author RA M M+F M+F M+F M+F&lt;/div&gt;</summary>
		<author><name>Growthduck6</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Baby_Teeth_Stem_Cells&amp;diff=191784</id>
		<title>Baby Teeth Stem Cells</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Baby_Teeth_Stem_Cells&amp;diff=191784"/>
				<updated>2017-06-20T11:27:56Z</updated>
		
		<summary type="html">&lt;p&gt;Growthduck6: Створена сторінка: : human participants without the need of limitation of sex or geographic location, case-control or [http://www.medchemexpress.com/HG6-64-1.html HG6-64-1 web] Co...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;: human participants without the need of limitation of sex or geographic location, case-control or [http://www.medchemexpress.com/HG6-64-1.html HG6-64-1 web] Cohort studies, prior medical history of RA as exposure, MM as outcome, research that reported relative threat, standardized incidence ratio or odds ratio of MM individuals with prior history of RA, publication in English. Moreover, the selection of cohort studies for inclusion was made no matter certain RA management techniques. Case series, case reports, in vitro and animal studies were excluded. Eligibility assessment was performed independently by two reviewers, and disagreements resolved by consensus. The Newcastle-Ottawa Scale, developed for evaluating the good quality of nonrandomized research, was employed by two independent reviewers to assess the methodological high-quality of every study, and the scores subsequently applied in subgroup evaluation. A score of #5 was deemed as relative low high-quality. Statistical Analyses In case-control research, OR and 95% CIs for MM danger components have been straight extracted from original analysis papers or calculated when not supplied. The primary outcome for cohort research was SIR and corresponding 95% CI. In cases where SIRs had been not specifically reported, calculations had been made from the variety of observed MM divided by the amount of anticipated instances inside the basic population provided by authors, and 95% CI determined employing the standard error from the natural logarithm of SIR, estimated from the inverse in the square root with the observed number of cases. The measure of interest was RR, estimated from ORs in case-control studies and SIRs in cohort research. Since the incidence of MM is low, SIR and OR make comparable estimate of RR, hence we present all results as RR for simplicity. Between-study heterogeneity was examined making use of a chi-square test of heterogeneity and I2 measure of inconsistency. P-values less than 0.1 or the I2 statistic greater than 50% have been thought of statistically important. Beneath these situations, information had been pooled primarily based on the strategy of Dersimonian and Laird below a random effects model otherwise beneath fixed effects model. Twotailed p#0.05 was thought of statistically important for all analyses. To evaluate publication bias, we constructed a funnel plot and applied Begg's test. Trim and Fill evaluation was utilized to estimate the amount of missing studies and their potential effects on outcomes. Sensitivity analyses have been also conducted to ascertain the robustness of our findings. The influence of RA was examined by excluding research restricted to elderly sufferers or Data Extraction Two authors performed data extraction independently, and any discrepancies have been addressed by discussion and re-evaluation. We obtained information and facts around the author, year of publication, country of origin, supply of case, manage and cohort, controlled aspects, diagnosis criteria and remedy regimen for RA. Cohort size, quantity of situations, cohort duration, SIR and 95% self-confidence intervals or enough data to enable calculation of those numbers have been additionally necessary for  cohort research. For casecontrol research, the exact numbers of instances and controls by RA, OR and 95% CIs were necessary. For the goal of ascertaining the relationship among MM and other  autoimmune illnesses, connected information were recorded, where out there, based on the above extraction principles. 2 Author RA M M+F M+F M+F M+F&lt;/div&gt;</summary>
		<author><name>Growthduck6</name></author>	</entry>

	</feed>